February 27, 2013 -- SFL is pleased to announce its participation at the 25th DIA Annual EuroMeeting
in
Amsterdam, 4
-
6 March 2013. This year’s meeting will feature over 110 sessions and is
expected to attract more than 3,000 professionals involved in the development of
medicines from more than 50 countries. As in previous years, SFL’s team is heavily inv
olved
in the DIA meeting, serving as a Member of the DIA EuroMeeting Program Committee.
On Tuesday 5 March 2013 morning, Shayesteh Fürst
-
Ladani, SFL’s Managing Director, will
be chairing the session “Current Status of Revision of EU Medical Devices Direct
ives”. This
session will assess key developments and present the positions of stakeholders, including
industry, at a time when the proposals are debated by the European Parliament and later
the Council of the EU. She will be presenting an overview on the r
evision of medical devices
and In Vitro Diagnostics Directives.
Amanda Maxwell, Head of the UK office of SFL, will be chairing and speaking in the Tuesday
morning session on EU approval of drug/device combinations, the new regulatory structure
and how it
will impact innovation. Samantha Regenthal, Head Legal Services at SFL, will be
chairing and speaking a session on legal compliance for regulatory functions, highlighting
learnings from recent legal cases and other enforcement activities. On Wednesday 6 Ma
rch,
Anna Hallersten, SFL’s Public Affairs Director will present
on the role of Ethics Committees in
the proposed Clinical Trial Regulation.
Outside the main sessions, attendees can also meet the SFL team at the company’ exhibition
booth (
#613
). The team w
ill be happy to answer questions and provide further information
on the company’s expertise in Regulatory Affairs, Public Affairs, Legal Services and Medical
Communications. If you would like to arrange a meeting in advance, please send us an email at
office@sfl
-
services.com
.
About SFL Regulatory Affairs & Scientific Communication Ltd
SFL is dedicated to a holistic approach to lifecycle management
of healthcare products from
nonclinical and clinical studies through to registration and post
-
approval activities. The SFL
team members have experience in Regulatory Affairs, Public Affairs, Legal Services and
Medical Communications, and provide personali
zed and comprehensive services. When
combined, these services comprise an integral oversight package for products from the
bench to the marketplace at one consultancy. SFL also provides specialized training courses
where participants can benefit from the t
eam’s cross
-
functional expertise
.
For more information, please contact:
Faiz Kermani, PhD
Senior Communication Manager
SFL Regulatory Affairs & Scientific Communication Ltd
Hochstrasse 51
,
CH
-
4002 Basel,
Switzerland
Tel: +41 61 361 9443
Fax: +41 61
361 9442
Email: office@sfl
-
services.com
Web: www.sfl
-
services.com